日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Drosophila melanogaster Polypeptide N-acetylgalactosaminyltransferase 35A (Pgant35A), partial CSB-YP847598DLU
CSB-EP847598DLU
CSB-BP847598DLU
CSB-MP847598DLU
CSB-EP847598DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum PA-phosphatase related-family protein DDB_G0275547 (DDB_G0275547), partial CSB-YP847599DKK1
CSB-EP847599DKK1
CSB-BP847599DKK1
CSB-MP847599DKK1
CSB-EP847599DKK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Myosin heavy chain kinase C (mhkC), partial CSB-YP847600DKK
CSB-EP847600DKK
CSB-BP847600DKK
CSB-MP847600DKK
CSB-EP847600DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative polypeptide N-acetylgalactosaminyltransferase 13 (pgant13), partial CSB-YP847601DLU
CSB-EP847601DLU
CSB-BP847601DLU
CSB-MP847601DLU
CSB-EP847601DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penaeus monodon Beta-1,3-glucan-binding protein CSB-YP847602ETF
CSB-EP847602ETF
CSB-BP847602ETF
CSB-MP847602ETF
CSB-EP847602ETF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Uncharacterized protein C1orf87 (C1orf87) CSB-YP847603HU
CSB-EP847603HU
CSB-BP847603HU
CSB-MP847603HU
CSB-EP847603HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human L-fucose kinase (FUK), partial CSB-YP847604HU
CSB-EP847604HU
CSB-BP847604HU
CSB-MP847604HU
CSB-EP847604HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human V-set and immunoglobulin domain-containing protein 10 (VSIG10), partial CSB-YP847605HU
CSB-EP847605HU
CSB-BP847605HU
CSB-MP847605HU
CSB-EP847605HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Cytochrome P450 4X1 (CYP4X1), partial CSB-YP847606HU1
CSB-EP847606HU1
CSB-BP847606HU1
CSB-MP847606HU1
CSB-EP847606HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Protein FAM177A1 (FAM177A1) CSB-YP847607HU
CSB-EP847607HU
CSB-BP847607HU
CSB-MP847607HU
CSB-EP847607HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Outer row dynein assembly protein 16 homolog (WDR69) CSB-YP847608HU
CSB-EP847608HU
CSB-BP847608HU
CSB-MP847608HU
CSB-EP847608HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Gap junction delta-3 protein (GJD3), partial CSB-YP847609HU1
CSB-EP847609HU1
CSB-BP847609HU1
CSB-MP847609HU1
CSB-EP847609HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein (SLC22A18AS) CSB-YP847610HU
CSB-EP847610HU
CSB-BP847610HU
CSB-MP847610HU
CSB-EP847610HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (FTSJD2), partial CSB-YP847611HU
CSB-EP847611HU
CSB-BP847611HU
CSB-MP847611HU
CSB-EP847611HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative cytochrome P450 family member 4Z2 (CYP4Z2P), partial CSB-YP847612HU
CSB-EP847612HU
CSB-BP847612HU
CSB-MP847612HU
CSB-EP847612HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Carbonic anhydrase 13 (CA13) CSB-YP847613HU
CSB-EP847613HU
CSB-BP847613HU
CSB-MP847613HU
CSB-EP847613HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Transmembrane protein FLJ37396, partial CSB-YP847614HU1
CSB-EP847614HU1
CSB-BP847614HU1
CSB-MP847614HU1
CSB-EP847614HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Nesprin-4 (C19orf46), partial CSB-YP847615HU
CSB-EP847615HU
CSB-BP847615HU
CSB-MP847615HU
CSB-EP847615HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Ankyrin repeat domain-containing protein 35 (ANKRD35), partial CSB-YP847616HU
CSB-EP847616HU
CSB-BP847616HU
CSB-MP847616HU
CSB-EP847616HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Uncharacterized protein C21orf128 (C21orf128) CSB-YP847617HU
CSB-EP847617HU
CSB-BP847617HU
CSB-MP847617HU
CSB-EP847617HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×